Scinai Immunotherapeutics (SCNI) Enterprise Value (2015 - 2026)
Scinai Immunotherapeutics (SCNI) reported Enterprise Value of -$3.1 billion for Q1 2026, down 270918.28% on a YoY basis from N/an in Q1 2025, and down 1953.26% sequentially from -$151.7 million in Q4 2025.
Scinai Immunotherapeutics (SCNI) Enterprise Value (2015 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 12 years of Enterprise Value data on file, last reported at -$3.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 270918.28% year-over-year to -$3.1 billion; the trailing twelve-month figure through Mar 2026 stood at -$3.1 billion (down 270918.28% YoY), and the FY2025 full-year result was -$151.7 million, down 7139.19% from the prior year.
- Enterprise Value retreated to -$3.1 billion in Q1 2026, from -$151.7 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$1.1 million in Q1 2025 to a low of -$3.1 billion in Q1 2026.
- A 5-year average of -$211.4 million and a median of -$10.1 million in 2022 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 77.69% in 2025 and slumped 270918.28% in 2026, its largest moves.
- Tracing SCNI's Enterprise Value over 5 years: stood at -$14.2 million in 2022, then surged by 64.76% to -$5.0 million in 2023, then soared by 58.18% to -$2.1 million in 2024, then slumped by 7139.19% to -$151.7 million in 2025, then sank by 1953.26% to -$3.1 billion in 2026.
- Business Quant data shows SCNI's Enterprise Value at -$3.1 billion in Q1 2026, -$151.7 million in Q4 2025, and -$1.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | -3.11 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.11 Bn |
| Dec 31, 2025 | -151.66 Mn |
| Jun 30, 2025 | -1.27 Mn |
| Mar 31, 2025 | -1.15 Mn |
| Dec 31, 2024 | -2.10 Mn |
| Sep 30, 2024 | -5.15 Mn |
| Jun 30, 2024 | -3.35 Mn |
| Mar 31, 2024 | -5.15 Mn |
| Dec 31, 2023 | -5.01 Mn |
| Sep 30, 2023 | -14.34 Mn |
| Jun 30, 2023 | -14.34 Mn |
| Mar 31, 2023 | -14.34 Mn |
| Dec 31, 2022 | -14.22 Mn |
| Sep 30, 2022 | -8.58 Mn |
| Jun 30, 2022 | -11.56 Mn |
| Mar 31, 2022 | -15.39 Mn |
| Dec 31, 2021 | -17.52 Mn |
| Sep 30, 2021 | -10.74 Mn |
| Jun 30, 2021 | -48.58 Mn |
| Mar 31, 2021 | -2.83 Mn |